TRISSA ADAMS: Open Payments
NPI 1598147258 · ELLENVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,186 in 49 payments from 13 companies in 2025. Trend: 2023 $125 · 2024 $729 · 2025 $1,186
Food & beverage: $1,186
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $247 |
| Alkermes, Inc. | 5 | $208 |
| Teva Pharmaceuticals USA, Inc. | 4 | $191 |
| ABBVIE INC. | 19 | $185 |
| Supernus Pharmaceuticals, Inc. | 1 | $103 |
| Otsuka America Pharmaceutical, Inc. | 4 | $73 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Lundbeck LLC | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
Products named: CAPLYTA, VRAYLAR, AUSTEDO XR, LYBALVI, Qelbree, ARISTADA, REXULTI, Auvelity.
Industry payments across NY — which companies pay providers there.
